MOHAMMAD AL-RAIE: Open Payments
NPI 1629345848 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 64 payments from 16 companies in 2025. Trend: 2023 $767 · 2024 $923 · 2025 $1,087
Food & beverage: $1,087
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $287 |
| Novo Nordisk Inc | 9 | $239 |
| Viatris Specialty LLC | 4 | $99 |
| Exact Sciences Corporation | 3 | $64 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Amgen Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
Products named: Ozempic, QULIPTA, VRAYLAR, YUPELRI, REXULTI, TRELEGY ELLIPTA, XIFAXAN, The Cologuard Plus Collection Kit.
Industry payments across NM — which companies pay providers there.
